JBCHEPHARM - Technical Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Technical Rating: 4.5

Here’s your full technical analysis on J. B. Chemicals & Pharmaceuticals Ltd (JBCHEPHARM) — this one’s riding high with notable momentum, though signs of short-term exhaustion are emerging

📊 Trend & Price Dynamics

Current Price ₹1,803 is well above both 50-DMA (₹1,679) and 200-DMA (₹1,693) → confirms strong bullish trend continuation.

Stock is ~11% off its 52-week high ₹2,030 and ~38% above its low ₹1,303.

52w Index: 68.7% → clear long-term upward bias with strong momentum over the year.

🧭 Trend Status: Trending upward, though RSI suggests possible near-term consolidation.

📉 Momentum Indicators

RSI (71.8): Enters overbought territory → may invite short-term pullbacks or profit-taking.

MACD (12.9): Positive crossover and widening → indicates ongoing bullish momentum.

Volume (10.8L) vs 1W Avg (4.9L) → significant surge, confirming strong breakout activity.

📈 Momentum Verdict: Highly bullish; however, elevated RSI could signal short-term overheating.

📈 Bollinger Bands & Volatility

Price likely hugging the upper band, which reinforces trend but also increases reversal risk.

Expanded bandwidth suggests volatility is elevated — potential sharp moves ahead.

🧱 Support & Resistance Zones

Zone Type Price Range (₹) Commentary

Support 1,755–1,775 Prior breakout level; strong buyer interest zone

Resistance 1,980–2,030 52-week high territory; probable profit-booking

Breakdown Below ₹1,740 Would weaken trend and call for re-evaluation

🎯 Trade Strategy

Entry Zone: ₹1,765–₹1,780 (minor pullback opportunity near support)

Exit Zone: ₹1,980–₹2,030 (target top range; aggressive traders may trail stops)

Stop Loss: ₹1,740 (tight trailing protection)

📌 Conclusion

JBCHEPHARM is trending strongly, supported by heavy volume and bullish indicators.

Traders can ride momentum with caution near resistance — look for confirmation before fresh longs.

A breakout above ₹2,030 backed by MACD expansion and RSI reset could open room to ₹2,100+.

Want to line up this chart against peers like Alkem, IPCA, or Glenmark for pharma sector sentiment analysis? I can prep the comparative trend map for you 🧬📊

Edit in a page